{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:20:13Z","timestamp":1759882813375,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/s0377-1237(08)80065-2","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T10:08:34Z","timestamp":1307700514000},"page":"161-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dengue Vaccine: The Current Status"],"prefix":"10.1016","volume":"64","author":[{"given":"MS","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VK","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0377-1237(08)80065-2_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue haemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin Microbiol Review"},{"key":"10.1016\/S0377-1237(08)80065-2_bib2","first-page":"639","article-title":"Dengue vaccines: problems and prospects","volume":"5","author":"Chaturvedi","year":"2005","journal-title":"Indian J Med Res"},{"key":"10.1016\/S0377-1237(08)80065-2_bib3","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1128\/JVI.77.7.4463-4467.2003","article-title":"Diverse dengue Type 2 virus populations contain recombinant and both parental viruses in a single mosquito host","volume":"77","author":"Craig","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/S0377-1237(08)80065-2_bib4","first-page":"308","article-title":"Understanding dengue pathogenesis: implications for vaccine design","volume":"83","author":"Stephenson","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S0377-1237(08)80065-2_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/jcm.30.3.545-551.1992","article-title":"Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction","volume":"30","author":"Lancotti","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S0377-1237(08)80065-2_bib6","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/S0264-410X(01)00020-2","article-title":"Safety and immunogenicity of attenuated dengue virus vaccines in human volunteers","volume":"19","author":"Kanesa-thasan","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/S0377-1237(08)80065-2_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4269\/ajtmh.2002.66.264","article-title":"Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: Role of serotype concentration, ratio, and multiple doses","volume":"66","author":"Sabchareon","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S0377-1237(08)80065-2_bib8","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1128\/JVI.79.9.5516-5528.2005","article-title":"Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys","volume":"79","author":"Blaney","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/S0377-1237(08)80065-2_bib9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(02)11276-1","article-title":"The future of dengue vaccines","volume":"360","author":"Halstead","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S0377-1237(08)80065-2_bib10","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1128\/jvi.70.6.4162-4166.1996","article-title":"Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge","volume":"70","author":"Bray","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/S0377-1237(08)80065-2_bib11","first-page":"1","article-title":"Determining genetic stabilities of chimaeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative Taq MAMA","volume":"13","author":"Butrapet","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/S0377-1237(08)80065-2_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30-nucleotide deletion in its 3'- untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S0377-1237(08)80065-2_bib13","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimaeric yellow fever-dengue Type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/S0377-1237(08)80065-2_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/viro.2002.1462","article-title":"Viraemia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimaeric vaccine: Genetic reconstructions, dose adjustment and antibody responses against wild-type dengue virus isolates","volume":"298","author":"Guirakhoo","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/S0377-1237(08)80065-2_bib15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0042-6822(92)90267-S","article-title":"The Murray valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of the E glycoprotein","volume":"191","author":"Guirakhoo","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/S0377-1237(08)80065-2_bib16","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.4049\/jimmunol.156.10.3579","article-title":"Novel vaccine approaches","volume":"56","author":"Ertl","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S0377-1237(08)80065-2_bib17","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/S0264-410X(00)00121-3","article-title":"Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue Type 2 virus challenge","volume":"18","author":"Men","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/S0377-1237(08)80065-2_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-3156.2003.01159.x","article-title":"The challenge of dengue vaccine development and introduction","volume":"9","author":"Jacqueline","year":"2004","journal-title":"Trop Med and International Health"},{"key":"10.1016\/S0377-1237(08)80065-2_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000050045","article-title":"Development of new vaccines against dengue fever and Japanese encephalitis","volume":"44","author":"Kinney","year":"2001","journal-title":"Intervirology"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123708800652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123708800652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:39:36Z","timestamp":1759837176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123708800652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0377123708800652"],"URL":"https:\/\/doi.org\/10.1016\/s0377-1237(08)80065-2","relation":{},"ISSN":["0377-1237"],"issn-type":[{"type":"print","value":"0377-1237"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dengue Vaccine: The Current Status","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0377-1237(08)80065-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Director General, Armed Forces Medical Services. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}